Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a Superior Predictive Marker.
Saved in:
| Title: | Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a Superior Predictive Marker. |
|---|---|
| Authors: | Stöth, Manuel1 (AUTHOR) stoeth_m@ukw.de, Müller-Diesing, Flurin1,2 (AUTHOR), Mack, Patricia1,3 (AUTHOR), Ackermann, Laura1 (AUTHOR), Metz, Corona2,3 (AUTHOR), Grunz, Jan-Peter3 (AUTHOR), Hackenberg, Stephan1 (AUTHOR), Goncalves, Miguel1 (AUTHOR), Gehrke, Thomas1 (AUTHOR), Meyer, Till Jasper1 (AUTHOR), Scherzad, Agmal1 (AUTHOR) |
| Source: | International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 18, p9154. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms26189154 |
